INM · InMed Pharmaceuticals Inc.
$1.51
+0.05 (+3.42%)
At close · Aug 4
Going-concern doubt
— flagged May 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has concluded that there is substantial doubt about its ability to continue as a going concern within one year after the date that the condensed consolidated financial statements are issued. management has determined that the Company's liquidity condition raises substantial doubt about the Company's ability to continue as a going concern, which is considered to be for a period of one year from the issuance of these financial statements.”View the 10-Q filed May 6, 2026
Market Cap
$4.84M
Shares
3.31M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2025-12-11 | Life Sciences Virtual Investor Forum | Event |
| 2025-09-18 | InMed Presenting at Life Sciences Investor Forum | Event |
| 2024-11-12 | Fierce Biotech Webinar: Alzheimer’s Outlook – Neuroinflammation, the Next Step | Event |
| 2024-08-01 | Alzheimer’s Association International Conference® | Conference |
| 2024-06-20 | Benzinga Healthcare + Biotech Breakthroughs | Event |
| 2024-06-13 | Emerging Growth Conference | Conference |
| 2024-02-01 | The Microcap Conference 2024 | Conference |
| 2024-01-25 | Water Tower Research Fireside Chat with InMed CEO Eric A. Adams | Event |
| 2023-12-01 | MJ Biz Con | Event |
| 2023-11-07 | 12th World Congress on Itch (WCI) 2023 | Event |
| 2023-06-01 | Investor Summit | Event |
| 2023-05-31 | Tribe Public Webinar | Event |
| 2023-05-23 | Fireside Chat with Water Tower Research | Event |